Eugene S Kim

2PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 11, 2021
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice.

Michael John Zobel, Abigail K Zamora, Hong-Wei Wu

|Sep 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma.

Wesley E Barry, Jeremy R Jackson, Grace E Asuelime

Pageof 1

Frequent Collaborators

1 joint publications

Michael John Zobel

1 joint publications

Michael A Sheard